Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3108646 Target Snapshot

Histone-lysine N-methyltransferase NSD3 · SINGLE PROTEIN · Homo sapiens

159Compounds
136Assays
1Approved Drugs
116.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9BZ95. Use UniProt Q9BZ95 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9BZ95 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone-lysine N-methyltransferase NSD3 as ChEMBL target CHEMBL3108646, mapped to UniProt Q9BZ95. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone-lysine N-methyltransferase NSD3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3108646
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9BZ95
Histone-lysine N-methyltransferase NSD3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone-lysine N-methyltransferase NSD3 is the right protein anchor across sources, using UniProt Q9BZ95 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone-lysine N-methyltransferase NSD3
UniProt AccessionQ9BZ95
Component TypeProtein
Sequence Length1437 aa

Histone-lysine N-methyltransferase NSD3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone-lysine N-methyltransferase NSD3, mapped to UniProt Q9BZ95. Sequence length is 1437 aa.

Mapped IDQ9BZ95
Review nameHistone-lysine N-methyltransferase NSD3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
3
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5071.0
EC503.0
KD42.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5396709 9.0 IC50 1.0 Preclinical
CHEMBL5408212 9.0 IC50 1.0 Preclinical
CHEMBL5419719 9.0 IC50 1.0 Preclinical
CHEMBL5425629 9.0 IC50 1.0 Preclinical
CHEMBL5432302 9.0 IC50 1.0 Preclinical
CHEMBL5433029 9.0 IC50 1.0 Preclinical
CHEMBL5438312 9.0 IC50 1.0 Preclinical
CHEMBL1232461 7.52 Kd 30.0 Clinical
CHEMBL5416709 7.34 Kd 46.0 Preclinical
CHEMBL4758943 7.04 Kd 91.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
18
5.5
8
6.0
13
6.5
3
7.0
1
7.5
0
8.0
0
8.5
7
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

136
Total Assays
62
Tested Compounds
2
Assay Types
Binding — 134 assays, 62 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 72 20 5.7
cell-based format 46 10 7.8
assay format 16 32 5.4
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine